In the intricate landscape of non-small cell lung cancer (NSCLC), tumor-infiltrating effector T cell subsets emerge as potent mediators of anti-tumor immunity, characterized by their robust expression of cytokines such as IFN-γ and TNF-α, which are pivotal in orchestrating immune responses against malignancies. This evidence concerns the gene IFNG and neoplasm.